Support for Patients and Communities Reauthorization Act
Official title: To reauthorize certain programs that provide for opioid use disorder prevention, recovery, and treatment, and for other purposes.
More subjectsShow fewer subjects
| Date | Chamber | What was voted on | Result | Yes–No | |
|---|---|---|---|---|---|
| Dec 12, 2023 | House · vote #715 | On Motion to Suspend the Rules and Pass, as Amended | Passed | 386–37 | See who voted → |
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Support for Patients and Communities Reauthorization Act
This bill reauthorizes through FY2028 and modifies various grants, programs, and activities that address substance use and misuse.
This includes reauthorizing (1) data collection, education, and surveillance activities; (2) grants and other support for substance use disorder prevention, treatment, and recovery; (3) student loan repayment and other programs for the substance use disorder workforce; and (4) programs for addressing trauma, particularly for children, youth, and their families. Generally, the modifications expand programs.
Additionally, the bill modifies provisions related to the scheduling of controlled substances, including by incorporating illicit xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer) into schedule III of the Controlled Substances Act.
Further, the bill makes permanent a requirement that Medicaid programs cover medication-assisted treatment for individuals with substance use disorders.
- Engrossed in House Formatted Text PDF Formatted XML
- Introduced in House Formatted Text PDF Formatted XML
- Referred in Senate Formatted Text PDF Formatted XML
- MASSACHUSETTS MEDICAL SOCIETY
- SPLITOAK STRATEGIES LLC
- BLUE CROSS BLUE SHIELD OF MICHIGAN
- BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC.
- ALPINE GROUP PARTNERS, LLC.
- BLUE CROSS AND BLUE SHIELD ASSOCIATION
Bodies those filers lobbied
- HOUSE OF REPRESENTATIVES
- SENATE
- Centers For Medicare and Medicaid Services (CMS)
- Health & Human Services, Dept of (HHS)
- Drug Enforcement Administration (DEA)
- Executive Office of the President (EOP)
- Food & Drug Administration (FDA)
- Health Resources & Services Administration (HRSA)
Cite this page
U.S. Congress. (2026). H.R. 4531: Support for Patients and Communities Reauthorization Act. 118th Congress. Open America. https://openamerica.io/bill/118-HR-4531/
"H.R. 4531: Support for Patients and Communities Reauthorization Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-4531/.
H.R. 4531, 118th Cong. (2026), https://openamerica.io/bill/118-HR-4531/.
[H.R. 4531: Support for Patients and Communities Reauthorization Act](https://openamerica.io/bill/118-HR-4531/)